Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Cytek Biosciences Q2 Earnings

  Cytek Biosciences (NASDAQ:CTKB) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:03 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Cytek Biosciences (NASDAQ:CTKB) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:03 PM.

Here’s what investors need to know about the announcement.

Earnings

Cytek Biosciences beat estimated earnings by 50.0%, reporting an EPS of $0.03 versus an estimate of $0.02.

Revenue was up $9.75 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 9.72% increase in the share price the next day.

 

To track all earnings releases for Cytek Biosciences visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Reports: Justice Department Investigating Lordstown Motors

By FreightWaves
Today, 11:34 PM
The Justice Department is probing financially troubled Lordstown Motors Corp., according to several media reports Friday. It is the latest blow to the company that plans to begin building battery-powered commercial pickup trucks this fall at a former General Motors plant in the northeast Ohio town from which it took its name and where GM built cars for 54 years.

RIDE